Use of Crystalloid and Colloid Solutions in Cardiopulmonary Bypass: LiteratureReview and Clinical Applications

Authors

DOI:

https://doi.org/10.5281/zenodo.13863801

Keywords:

Prime solution, Crystalloid, Colloid, Extracorporeal circulation, Cardiopulmonary bypass

Abstract

Prime solutions are solutions used during cardiopulmonary bypass (CPB) procedures to remove air by filling the circulatory system.  Prime solutions are solutions used during CPB procedures and are intended to remove air by filling the circulatory circuit. These solutions are generally divided into two main categories: crystalloid and colloid. Crystalloid solutions are more cost-effective and rapidly distributed in the body, while colloids provide effective volume support by maintaining intravenous volume for a longer period of time. The choice of prime solution is based on various factors such as the patient's health status, specific surgical intervention requirements and potential allergic reactions. An ideal prime solution should be carefully selected to cause minimal inflammatory responses while providing effective haemodilution.

Most patients undergoing cardiac surgery require circulatory support with CPB. During CPB, maintaining acid-base balance and electrolyte levels of body fluids has important effects on various organ systems. These organ systems include the central nervous system, the urinary system and the circulatory system, and affecting these systems can directly affect the outcome of cardiac surgery. However, worldwide research has shown significant variation in CPB techniques and prime solution preparation. The reasons for these differences and their impact on clinical outcomes remain unclear, and the choice of CPB prime solutions is often based on personal preference and historical beliefs. This review was written to emphasise the importance, types and selection criteria of prime solutions used during cardiopulmonary bypass procedures.

References

Hann KG, Likosky DS, Murkin JM. An evidence-basedreview of the practice of cardiopulmonary bypass in adults: a focus on neurologicinjury, glycemiccontrol, hemodilution, and the inflammatoryresponse. J ThoracCardiovascSurg. 2006; 132: 283-290.

Liskaser F, Story DA, Hayhoe M, Poustie SJ, Bailey MJ, Bellomo R. Effect of pump prime on acidosis, strong-ion-difference and unmeasuredionsduringcardiopulmonary bypass. AnaesthIntensiveCare. 2009; 37: 767-772.2

Lilley A. The selection of priming fluids for cardiopulmonary bypass in the UK and Ireland. Perfusion. 2002; 17: 315-319.

Miles LF, Coulson TG, Galhardo C, Falter F. Pump priming practices and anticoagulation in cardiacsurgery: resultsfrom the global cardiopulmonary bypass survey. AnesthAnalg. 2017; 125: 1871-1877.

G Walker PG, Constable PD, Morin DE, Foreman JH, Drackley JK, Thurmon JC, 1998. Comparison of hypertonicsaline-dextran solution and lactatedRinger'ssolution for resuscitatingseverelydehydratedcalves with diarrhea. JAVMA. 1998; 213:113-121.

G McCahon R., Hardman J., 2010. Pharmacology of plasmaexpanders. Anaesthesia&IntensiveCareMed, 11, 75-77

Iriz E, Kolbakir F, Akar H, Adam B, Keceligil HT. Comparison of hydroxyethyl starch and ringer lactate as a prime solution regarding S-100beta protein levels and informative cognitive tests in cerebral injury. Ann Thorac Surg. 2005;79(2):666-71.

Shippy CR, Appel PL, Shoemaker WC. Reliability of clinicalmonitoring to assess blood volume in criticallyillpatients. CritCareMed. 1984;12:107-12.

Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. SPLIT Investigators; ANZICS CTG. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. JAMA. 2015;314(16):1701-10.

Boldt J, Zickmann B, Rapin J, Hammermann H, Dapper F, Hempelmann G. Retracted: Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand. 1994;38(5):432-8.

Zornow MH., et all: Fluidmanagement in patients with traumaticbraininjury. New Horiz 3:488-498, 1995.

Swisher SN. Overview of freshfrozenplasma. In FreshFrozen Plasma: Indications and Risk. Bethesda, MD: NIH Consensus Development Conference,13-18, 1984.

Martin DJ, Lucas CE, Ledgerwood AM, Hoschner J, McGonigal MD, Grabow D. Freshfrozenplasmasupplement to massivered blood celltransfusion. Ann Surg, 202:505-10, 1985

Takagi M, Tanaka T, Ogata K. Evidence for exclusive biosynthesis in vivo of serum albumin by bound polysomes of rat liver. J Biochem. 1969;65(4):651-3.

Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. JPEN J Parenter Enteral Nutr. 1991;15(4):476-83.

Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. 1988;8(2):385-401.

Batlle J, del Río F, López Fernández MF, Martín R, López Borrasca A. Effect of dextran on factor VIII/von Willebrand factor structure and function. Thromb Haemost. 1985;54(3):697-9.

Toraman F. Kalp Cerrahisinde Sıvı Elektrolit Tedavisi GKDA Derg. 2013;19(2):53-66.

Boldt j. Volume Therapy in Cardiac Surgery. Annals of Cardiac Anaesthesia,8:104, 2005.

Topaç T, Kocailik A. Koroner Bypass Ameliyatlarında Kullanılan Prime Solüsyonların Postoperatif Kan Transfüzyonuna Etkisi. Turk J ClinCardiovPerfusion. 2023;1(2): 47-52.

Hoşten T, Türkyılmaz N, Cesur S, Arıkan A, Bayram H, Topbaş Ö. On-pump açık kalp cerrahisinde priming solusyonu olarak kullanılan kolloidler ve kristaloidlerin sıvı dengesi üzerine etkilerinin karşılaştırılması. GKDA Derg. 2016; 22(3):99-104.

Damar E, Aksun M, Girgin S, Göktoğan T, Yilmaz E, Aran G, et al. Koroner arter bypass greft ameliyatlarında pompa prime solüsyonu olarak Ringer ve Ringer solüsyonuna eklenmiş %6’lık hidroksietil nişasta (130/0.4-HES) kullanımının hemodinamik, metabolik, renal ve hemostatik etkilerinin karşılaştırılması. 2012:22 - 31.

Demirok M, Dikmen Y, Demiroluk İŞ, Salihoğlu Z. (2014). Ringer Laktat ve Hes 200/0.5 Solüsyonları İle Sıvı Replasmanının Onkotik Basınç, Osmolarite ve Koagülasyon Faktörleri Üzerine Etkilerinin Karşılaştırılması. Cerrahpaşa Tıp Dergisi, 2014; 34(4).

Tiryakioğlu O. Kardiyopulmoner bypassta prime solüsyonu olarak 130/0.4-HES. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2012: 20(3), 684-685.

Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985;89(5):713-22.

Buhre W, Hoeft A, Schorn B, Weyland A, Scholz M, Sonntag H. Acute effect of mitral valvereplace- ment on extravascularlungwater in patientsreceivingcolloid or crystal- loid priming of cardiopulmonary bypass. Br J Anaesth. 1997;79:311- 316.

Hett DA, Smith DC. A survey of priming solutions used for cardiopul- monary bypass. Perfusion 1994;9:19-22.

Published

30.09.2024

How to Cite

Coşkun, M. B., Egi, K., & Cicek, A. (2024). Use of Crystalloid and Colloid Solutions in Cardiopulmonary Bypass: LiteratureReview and Clinical Applications. MEHES JOURNAL, 2(3), 58–67. https://doi.org/10.5281/zenodo.13863801

Issue

Section

Review Articles